The FHIT gene has been implicated as a tumor suppressor gene in human malignancies. To determine if FHIT alterations play a role in human squamous cell carcinogenesis of the head and neck (HNSCC), we examined the gene and its product by RT ± PCR, SSCP, Northern, Southern, and Western blot analysis in primary HNSCC and/or HNSCC cell lines. Three of 32 tumor samples lacked detectable expression of FHIT by RT ± PCR but showed ampli®cation of a control gene of similar size. One of 29 primary tumors and 2/9 HNSCC cell lines exhibited aberrant transcripts generated by RT ± PCR methods using one set of 40 cycles of ampli®cation. FHIT mRNA expression was absent in seven HNSCC cell lines but detectable in primary keratinocytes by Northern analysis. Using speci®c polyclonal antiserum to the full-length FHIT protein in immunoblot analyses, 4/9 cell lines analysed showed no expression of pFhit, two exhibited low levels of expression, and three expressed a putative truncated pFhit. One of 15 tumors analysed also exhibited an overexpressed truncated protein. PCR/SSCP and Southern analysis of one cell line DNA that expressed a truncated protein indicated that it sustained homozygous loss of FHIT exon 5. Our results suggest that alterations in FHIT at the DNA, RNA, and protein levels exist at a low but signi®cant frequency in HNSCCs. Further studies regarding the potential biological activity of FHIT are needed to clarify the role of this gene in HNSCC tumorigenesis.
Introduction
Squamous cell carcinomas of the head and neck (HNSCCs) account for nearly 5% of cancers in the US per year (Vokes et al., 1993) . Alcohol and tobacco exposure have been identi®ed as important risk factors for this disease (Jovanovic et al., 1993) . However, little is known regarding the molecular changes underlying this disease. Inactivation of tumor suppressor genes, (p53, p16) and ampli®cation or overexpression of cyclins, bcl-1, int-2, EMS1 and EGF receptors have been found in some HNSCCs (Bartkova et al., 1995; Berenson et al, 1989; Lammie et al, 1991; Merritt et al., 1990; Schuurins et al, 1992; Somers et al, 1990; Zhang et al., 1994 , for review, see Brachman, 1994 . In addition, frequent LOH has been found in several chromosomal regions in HNSCCs including those of 3p, 9p, 11q, 13q and 17p (Ah-See et al., 1994; Latif et al., 1992; Nawroz et al., 1994; Li et al., 1994) . Alterations in the p16 and p53 genes, located on 9p and 17p, respectively, may represent the critical tumor suppressor loci in these regions in HNSCC. The VHL gene resides on 3p, however this gene was not found to be deleted or mutated in HNSCC (Sakata, 1996; Waber et al., 1996) .
Recently, the FHIT gene, a putative tumor suppressor gene, was localized to chromosome 3p14.2 and was found to span both the t(3 : 8)(p14.2;q24) translocation breakpoint observed in familial renal cell carcinoma as well as the FRA3B constitutive and aphidicolin-sensitive fragile site Kastury et al, 1996) . FHIT encodes a protein that is 52% identical and 69% similar to diadenosine 5'5'''-P 1 P 4 tetraphosphate assymetrical hydrolase from Schizosaccharomyces pombe . It also exhibits dinucleoside 5'5''-P 1 P 3 -triphosphate hydrolase activity in enzymatic assays (Barnes et al., 1996) . The gene consists of ten exons which span over one megabase of DNA and exons 5 ± 9 encode the FHIT protein Druck et al., 1997) .
Aberrant transcripts identi®ed by RT ± PCR have shown in several dierent types of primary tumors and tumor-derived cell lines including small cell and nonsmall cell lung tumors, esophageal, gastric, beast, ovarian, cervical and Merkel cell tumors or tumorderived lines, as well as in HNSCCs (Fong et al., 1997; Gemma et al., 1997; Hendricks et al., 1997; Man et al., 1996; Mao et al., 1996; Negrini et al., 1996; Ohta et al., 1996; Sozzi et al., 1996a,b; Virgilio et al., 1996; Yanagisawa et al., 1996) . Aberrant RT ± PCR products have also been observed in colon carcinoma-derived cell lines by some investigators but the entire coding region of FHIT was normal in several primary colon tumor explants examined by other investigators (Thiagalingam et al., 1996) . Homozygous deletions and other alterations at the DNA level have also been described in some tumor-derived cell lines Druck et al., 1997; Fong et al., 1997; Hendricks et al., 1997) . Many studies have identi®ed deletions with borders occurring most often at exon-intron boundaries. These deletions could lead to mRNA transcripts that encode truncated FHIT proteins due to use of alternative start codons. However, few studies analysed FHIT protein expression. In addition, examination of the role of FHIT alterations in squamous cell carcinogenesis of the head and neck has primarily been limited to tumor-derived cell lines or short term cultures but not primary tumors. To further evaluate the role of FHIT alterations in HNSCC, a panel of HNSCC-derived cell lines and primary tumors were examined for alterations in FHIT by RT ± PCR analysis, single stranded conformation polymorphism analysis (SSCP), Northern, Southern and Western analysis.
Results

Examination of FHIT gene transcripts by RT ± PCR
Thirty-two primary HNSCCs and nine HNSCCderived cell lines (A253, FADU, Det 562 and SCC lines 4, 9, 15, 25, 40 and 66) were examined by RT ± PCR for aberrant-sized transcripts. Due to a potential risk of obtaining RT ± PCR artifacts, RT ± PCR methods were developed that allowed ampli®cation of the transcripts in a single set of 40 cycles. DMSO was added to each PCR reaction and Amplitaq Gold was used to increase the reaction speci®city. All samples were assayed using this protocol. Some samples did not exhibit ampli®cation upon the ®rst attempt (included in Figure 1 , lanes 11, 18, 19 and 22) . These samples were reassayed in separate, new RT and PCR reactions. These results indicate that FHIT expression was very low in these samples. In total, 3/32 primary tumor samples repeatedly failed to give ampli®ed fragments in the RT ± PCR reactions. The integrity of the RNA from these samples was checked by agarose gel electrophoresis then the samples were reverse-transcribed using oligo dT primers instead of the 3D2 primers. They were then subjected to 40 cycles of PCR ampli®cation using primers generating an approximately 688 bp fragment of the retinoic acid receptor a gene to ascertain that the RNA was intact and yielded ampli®able cDNA. Each of these samples showed robust ampli®cation of the RAR a gene (data not shown). One of 29 primary tumors and two of the nine HNSCC-derived cell lines, SCC 40 and SCC 9, exhibited aberrant transcripts by RT ± PCR. In each case, RT ± PCR resulted in the production of multiple fragments that were smaller than the expected FHIT fragment length of 692 bp with minimal or no normal sized FHIT product. These results were veri®ed by a second independent set of RT and PCR reactions. The RT ± PCR products from one sample, primary tumor 10-8, were cloned and sequenced to give a representation of the types of products obtained. Sequencing of several clones resulted in identi®cation of two dierent Fhit-speci®c fragments as well as a FHIT primer-dimer and some apparently non-speci®c products. One contained the expected message with a deletion of exons 5 ± 8 (inclusive), which has been reported previously. In addition, we identi®ed a Fhit fragment of 179 bp (bp 7220 to 741, on Fhit sequence in Ohta et al., 1996) encompassing part of exon 1, all of exons 2 and 3 and part of exon 4 but lacking the rest of the transcript. A gel showing the RT ± PCR results from several tumors and some cell lines is shown in Figure 1 . The results are also summarized in Table 1 .
Fhit protein expression in primary tumors and tumor-derived cell lines
To examine the expression of the FHIT gene product in HNSCC, polyclonal antisera were produced by inoculation of rabbits with recombinant full-length FHIT-GST-fusion protein. This antibody recognizes a 17 kDa protein consistent with the estimated molecular weight of pFhit. Figure 2 shows the characterization of the polyclonal anti-Fhit antibody which has also recently been described in detail (Xiao et al., 1997) . Western analysis showed that the anti-Fhit antiserum detected the thrombin-cleaved bacterial recombinant GST-Fhit protein, rFhit, that was used as the immunogen. It also recognized a speci®c 17 kDa band in the cell lysate of normal human kidney, in addition to a few non-speci®c larger bands. In HeLa cells where endogenous pFhit is absent, no immunoreactive proteins of 17 ± 20 kDa were detected by Western analysis with the polyclonal anti-Fhit antibody. However, expression of an approximately 18 kDa HA-tagged pFhit was readily detected following stable Figure 1 RT ± PCR analysis of HNSCC-derived cell lines and primary tumors. One ml of RT reaction product was added to 19 ml of PCR reaction mix and the samples were PCR-ampli®ed for 40 cycles using primers 3D1 and 5U2. Lanes 1 ± 11: primary HNSCCs, Lane 12: HaCat; immortalized human keratinocytes, Lane 13: SCC40, Lane 14: SCC 66. Lanes 15 ± 25: primary HNSCCs. Lane 26: 100 bp ladder. Lanes 7 and 13 which contain RT ± PCR products from HNSCCs`10-8' and SCC40 exhibit aberrant bands. Minor bands observed in other samples were observed from time to time in negative controls and may represent transcripts present in very low abundance or RT ± PCR artifacts transfection of an expression vector containing the full length FHIT cDNA into the HeLa cells. The slightly larger HA tagged-protein was also detected by anti-HA monoclonal antibody (BAbCo, Richmond, CA) (data not shown). Fifteen primary tumors and nine tumorderived cell lines were examined by Western analysis for Fhit protein expression. Figure 3 shows that three cell lines (SCC 15, 25 and 40) do not express normal pFhit; two cell lines, A253, and Det 562, express only trace amounts of pFhit, and three HNSCC-derived lines (FADU, SSC 9 and 66) express pFhit. SSC 4 also did not express normal pFhit (data not shown). The normal keratinocytes express pFhit but at a much lower level than normal kidney tissues (data not shown). Two of the nine HNSCC-derived cell lines, SCC 25 and 40, lacked the normal 17 kDa normal protein but exhibited a highly expressed smaller immunoreactive band. A similar band was observed in SCC 9 (Table 1, Figure 3 ). These fragments comigrate at the leading edge of the 15% SDS ± PAGE gel and thus do not necessarily represent the same size proteins. These aberrant proteins are clearly less than 14 kDa and do not appear to be degradation products. For the cell line samples, this is supported by highly reproducible results in multiple experiments using freshly prepared cell lysates prepared by individuals in two dierent laboratories. Also, there was no evidence of degradation of proteins of much higher molecular weights for these samples (data not shown) and lysates prepared from other tissues in a similar manner did not show these lower molecular weight bands (Xiao et al., 1997) . Two other lines (SCC12, 13) included on the immunoblot were derived from squamous cell carcinomas of the skin. Both of these expressed normal pFHIT and SCC 13 exhibited a smaller band also. Faint higher molecular weight bands were observed in some of the sample lanes, including the keratinocyte control lane, showing little or no normal Fhit expression. We believe that these are nonspeci®c bands. All of the primary tumors expressed low levels of pFhit ( Figure 4) . One of 15 primary tumors also exhibited an overexpressed truncated immuno- 52 mg of mRNA from this sample was loaded on gel shown, however repeat analysis of this sample with even loading also showed no expression (data not shown), 3 probable population polymorphism (G or A) 43 bp downstream from exon 6/intron 6 boundry Immunoblot analysis using anti-Fhit antiserum detects the thrombin-cleaved bacterial recombinant GST-Fhit protein, rFhit, that was used as an immunogen. It also recognizes a speci®c 17 kDa band in cell lysate of normal kidney, in addition to a few non-speci®c larger bands. In HeLa cells where endogenous pFhit is absent, expression of a *18 kDa HAtagged pFhit is readily detected following stable transfection with an expression vector containing the full-length human FHIT cDNA. The slightly larger HA-tagged protein is also detected by antiHA monoclonal antibody (BAbCo, Richmond, CA) (not shown) Figure 3 pFhit expression in HNSCC-derived cell lines. Cell lysates were made as described in the Materials and methods section then electrophoresed on 15% polyacrylamide gels containing SDS. Note that two independent cell lysates were assayed for the HNSCC cell line: SCC 40 reactive protein (Figure 4 and data not shown). Since only one lysate was available for analysis of primary tumors, the aberrant band could not be con®rmed in duplicate samples so the possibility remains that this could be a degradation product. Interestingly, we were unable to detect any normal or aberrant FHIT RT ± PCR products from this primary tumor sample though RT ± PCR ampli®cation of a similar sized fragment of the retinoic acid receptor alpha was successful, suggesting that the RNA was intact and ampli®able. That we did not detect altered transcript might be due to deletions or mutations that prevented binding of our PCR primers to the cDNA. Conversely, the levels of altered transcript, encoding the aberrant protein, may have been below the levels of detection of our RT ± PCR methods. It is possible that the mutated protein product is more stable than its message, allowing for its ecient detection by immunoblot analysis. Aberrations in pFhit expression were observed at a high frequency in HNSCC-derived cell lines: 6/9 lines showed very low levels or no pFhit and three lines exhibited an aberrant immunoreactive protein. However, only one alteration was seen in a primary HNSCC. Dierences in expression levels were not observed. Alterations in the levels of expression in the primary tumor samples may have been masked by expression of the proteins in normal tissue cells within the samples.
Northern analysis of HNSCC-derived cell lines
Northern analysis was performed on 7/9 of the HNSCC lines to determine the levels of FHIT expression quantitatively and to compare FHIT expression levels in HNSCCs with that in cultured normal primary keratinocytes. mRNA for Northern analysis was prepared from primary keratinocytes and SCC-derived cell lines when the lines were in an exponential growth phase. Two mg mRNA from each cell line sample, including a normal primary keratinocyte control (lane 8), were analysed ( Figure 5 and data not shown) and a lane containing 25 mg total RNA isolated from normal keratinocytes was also included (lane 9). Figure 5 shows that FHIT expression could not be detected in HNSCC-derived cell lines Detroit 562, A253, and SCC9. No bands were visible even after approximately ten days exposure of the membranes to autoradiography. However, a Fhit band of approximately 1.1 Kb was observed in both the cultured primary keratinocyte and SCC 12 lanes (lanes Figure 4 pFhit expression in primary tumors. Lane 4 shows overexpressed putative truncated FHIT protein Figure 5 Northern analysis of FHIT expression in HNSCC-derived cell lines. Top: Blot probed with FHIT cDNA (4 day exposure). Bottom: Blot probed with actin (1 h exposure). Lanes 1 ± 8 were loaded with approximately 2 mg mRNA isolated from the following tumor derived cell lines: SCC 9, SCC 13, SCC 40, A253, A431, SCC12, Det 562 and cultured human primary keratinocytes. Lane 9: 25 mg of total RNA from cultured primary human keratinocytes. Note that lane 3, containing mRNA from SCC 40, was underloaded. Thus, this sample in addition to others were evaluated on a second Northern blot (data not shown, see Table 1 ). SCCs 12 and 13 are squamous cell carcinoma-derived cell lines from skin and A431 is a cell line derived from an SCC of the lung 8 and 6, respectively). The latter cell line was derived from a squamous cell carcinoma of the skin. A faint signal was also detected in lane 9 which was loaded with 25 mg of total RNA from the primary keratinocytes and in lane 2, which contained mRNA isolated from another squamous cell carcinoma of the skin: SCC13. mRNA isolated from SCCs 15, 25, 40 and FADU and primary keratinocytes were analysed on a second Northern blot. Fhit expression was not detectable in the SCC lines but was observed in the lane loaded with primary keratinocyte mRNA (data not shown, see Table 1 ). These results demonstrate that FHIT expression is low in normal primary keratinocytes and not detectable in the HNSCC-derived cell lines derived from the oral cavity examined. Interestingly, FHIT mRNA is expressed more prominently in the two SCC lines that were derived from well dierentiated SCCs of the skin.
mRNA isolated from each of the cell line samples exhibiting the truncated proteins were included in our Northern analysis. No aberrant bands were observed by this analysis however, this is most likely the result of the dierences in sensitivity of the Northern and Western assays. However, the possibility exists that the aberrant pFhit is more stable than its message and can accumulate to greater (detectable) concentrations than the FHIT message.
Examination of tumor DNA for homozygous deletions and for point mutations by PCR and SSCP analyses PCR ampli®cation of FHIT exons 4 ± 9 from HNSCC cell line DNA samples was performed using primers based on intron sequences to examine the lines for homozygous deletion of FHIT coding regions (Druck et al., 1997) . In addition, 40 primary HNSCCs were examined for homozygous deletion of exon 5 of the FHIT gene by PCR ampli®cation. PCR products were run on agarose gels in the presence of ethidium bromide to visualize the bands. The PCR-based assays showed ampli®cation of all exons examined for every sample examined except for HNSCC cell line SCC40. Ampli®cation using exon 5-speci®c primers did not yield the expected fragment for SCC 40 (data not shown, see Figure 6a for SSCP results for this sample). This indicated that either exon 5 was homozygously deleted or that the intronic sequences complementary to the PCR primers used had sustained either mutations or deletions that precluded their binding and utility for ampli®cation. No other apparent homozygous deletions were observed in the HNSCC cell lines or primary tumors, however, this may have been due to the normal stromal tissue contamination in the case of the primary tumor samples (data not shown).
To determine whether there were small deletions or point mutations at the DNA level in the HNSCC cell lines, FHIT exons 4 ± 9 were ampli®ed and analysed by SSCP analysis. To optimize mutation detection, each sample was electrophoresed under two separate sets of conditions as noted in Materials and methods. We have found that this strategy increased the probability of mutation detection with other genes we have examined (T Goodrow, unpublished observations). No band shifts indicative of base changes or mutations were observed in exons 4, 5, 7 or 9 but band shifts were observed in FHIT exons 6 and 8 (Figure 6b and c) . Each band shift detected was veri®ed in a second separate PCR reaction and reanalysed by SSCP. The shifted bands were cut out and the DNA was isolated then reampli®ed for automated sequencing using an ABI sequencer (Foster City, CA). Two dierent variants were found in intron 6: a G or an A at 42 bases downstream of the exon 6-intron 6 boundry. The G variant was detected in cell lines A253, FADU, SCC 25 and SCC 40. The A variant was detected in Det 562 and SCCs 4, 9, 15 and 66. Both variants were detected in the normal lung tissue control. The two alleles observed in exon 8 Table 1 for speci®c base changes). Samples were electrophoresed on a 0.56TBE gel overnight at room temperature under nondenaturing conditions as described in Materials and methods represent known polymorphic variants. Sequencing of exon 8 PCR products from SCC lines 4 and 66 revealed a previously described polymorphic change in codon 98: (CAC?CAT) (Druck et al., 1997; Mao et al., 1996) . The normal lung DNA control and other cell lines contained the CAC variant. SSCP analysis also veri®ed independently that exon 5 was not ampli®able from DNA isolated from SCC 40 ( Figure  6a ). Exon 5 is the ®rst coding exon of the FHIT gene and contains the start site, however there is another potential in frame methionine codon in exon 6 . We observed a highly expressed putative FHIT protein of a reduced molecular weight in SCC 40 and it is possible that this protein may represent the translation product of a smaller transcript containing the alternative start codon that was identi®ed in exon 6. It should be noted that while our samples were subjected to SSCP under two dierent sets of conditions in order to better detect all possible mutations, it is possible that this technique may not allow detection of certain mutations.
Southern analyses of HNSCC-derived cell lines
To determine if alterations were present at the DNA level, 10 mg of DNA isolated from each HNSCCderived cell line were cut with HindIII then electrophoresed on an 0.8% agarose/Synergel (Diversi®ed Biotech, Newton Centre, MA) then analysed by Southern blotting using a PCR-generated FHIT cDNA probe containing exons 3 through 9. Figure 7 shows that three of eight cell lines assayed, SCC4, 40 and FADU, showed abnormal banding patterns (data not shown for Det. 562 and SCC 15 lines). SCC 40 lacked the 1.3 kb band that contains exon 5. This is consistent with SSCP and PCR data using speci®c primers for this region. SCC 4 showed only a trace of the 1.3 kb band containing exon 5 suggesting either partial loss or the complete loss of one allele of exon 5 for this sample. Conversely, there could be homozygous loss of regions of exon 5 in one fraction of the SCC4 cells and the presence of the normal allele in another fraction of cells. A similar ®nding has been described in other cell lines (Druck et al., 1997) . SCC 4 also showed only a trace of the 14 kb band suggesting partial loss or deletion of the region containing Fhit exon 8 (K Huebner, personal communication). However, it is possible that the lighter signal is partly due to an overall lighter signal for this sample. FADU exhibited an extra band of approximately 9 kb suggesting either a deletion or rearrangement in at least one allele of the FHIT locus in this line. Lastly, FADU and A253 showed a slightly lighter 1.3 kb band suggesting a possible deletion of exon 5 in at least some of the cells in these lines.
Discussion
We evaluated the status of the FHIT gene and its product in a series of tumor-derived cell lines and in primary tumors of the head and neck. We observed that steady state pFhit expression is relatively low in normal primary keratinocytes in comparison to normal human kidney (Xiao et al., 1997) . Seven of nine (78%) tumor-derived cell lines exhibited alterations in FHIT expression at the protein level which included either lack of detectable FHIT protein expression (4/9), decreased FHIT expression (2/9) or the presence of aberrant immunoreactive protein (3/9 samples). A lower frequency of aberrant expression patterns (1/15) was observed in primary tumors but this frequency may partly re¯ect the lack of detectable dierences in the level of pFhit expression due to the presence of normal stromal and in®ltrating cells that may express the protein. The lack of pFhit expression in HNSCCderived cell lines was corroborated at the RNA level by Northern analyses.
The aberrant immunoreactive proteins detected by Western blotting may represent mutant truncated FHIT proteins rather than FHIT degradation products or isoforms since our results were reproducible and our antibody has not detected any bands of this size in all of the normal tissues examined (Xiao et al., 1997) . The fact that the putative truncated pFhit appears to be strongly expressed in these tumors suggests that the mutant protein may be more stable than its normal counterpart; a phenomenon that has previously been documented with mutant p53 proteins. The role of the truncated proteins is not known but it is possible that they exert a dominant negative eect on the normal Fhit protein.
Genetic analysis of FHIT at the DNA and RNA levels revealed a low but signi®cant frequency of alterations in HNSCC-derived cell lines and primary HNSCCs. Three of nine HNSCC cell line samples revealed alterations at the DNA level: SCC 40 showed Figure 7 Southern analysis of HNSCC-derived lines. 10 mg of DNA were cut with HindIII then electrophoresed on an 0.8% agarose/Synergel, transferred to Hybond N + membranes and probed with the full length FHIT cDNA minus exon 10 as described in Materials and methods. Lane 1: normal lung tissue, Lanes 2 ± 7: A253, FADU, SCC66, SCC40, SCC 9, and SCC4 a deletion of exon 5 by PCR and Southern analyses, SCC 4 showed a partial deletion of exons 5 and 8 by Southern analysis and FADU exhibited an abnormal approximately 9 kb band by Southern analysis. Two of nine cell lines, SCC 40 and SCC9, exhibited alterations at the RNA level as determined by RT ± PCR. Four of 32 primary HNSCCs exhibited alterations by RT ± PCR including a lack of ampli®cation for three samples and abnormal RT ± PCR products for one sample. Many of the cell line and tumor samples exhibited light bands of the expected size upon RT ± PCR ampli®cation suggesting that FHIT message levels in these samples were very low. It is possible that FHIT expression was absent in the tumors and that the RT ± PCR products detected derived from ampli®cation of FHIT message from normal in®ltrating stromal cells. Cell lines SSC 9 and 40 as well as primary tumor`10-8' demonstrated reproducible aberrant transcripts by RT ± PCR with little of the expected 692 bp normal FHIT RT ± PCR product detectable. Each exhibited a series of RT ± PCR products. We cloned and sequenced the aberrant products from primary tumor 10-8 and found a transcript containing a deletion of exons 5 ± 8 in their entirety and another smaller fragment of Fhit containing part of exon 1 through exon 4. RT ± PCR products containing the exon 5 ± 8 deletion have been found by several groups. As suggested by others, the presence of a series of RT ± PCR products are most likely the result of the genomic instability at the FRA3B locus which is located in the same region as the FHIT gene locus.
RT ± PCR ampli®cation of Fhit from RNA isolated from the SCC lines resulted in visible bands upon electrophoresis, however RNA expression was not evident by Northern analysis. This is probably due to the higher sensitivity of PCR-based techniques. Protein expression was also low or absent in several lines which exhibited RT ± PCR ampli®cation of a normal-sized transcript, also probably re¯ecting the dierences in sensitivity of the RT ± PCR and Western techniques. Aberrant transcripts were not detected for SCC 25 or the primary tumor that exhibited an aberrant-sized protein: a very light normal sized transcript was observed for SCC 25 and no RT ± PCR Fhit product was obtained for the primary tumor, despite amplifiable RNA. These results suggest that either the amount of putative abnormal transcript(s) encoding the aberrant immunoreactive protein(s) was below the levels of detection of our assay or that the transcript may have contained deletions or mutations located in our PCR primer regions. There remains a small possibility that the aberrant-sized putative Fhit proteins are either degradation products or are present due to cross-reactivity of the polyclonal sera, however, reproducible results in the cell lines and characterization studies of the antibody (Xiao et al., 1997) suggest that this is not the case. The relative disparity between protein and RNA levels may be the result of an increased stability of the altered protein as mentioned.
The frequency of aberrant sized FHIT products detected by RT ± PCR in both of the HNSCC-derived lines (2/9) was similar to that reported in HNSCCderived cell lines (4/16) (Mao et al., 1996) but was lower than that found in short term cultures of primary tumors (Virgilio et al., 1996) . The observed frequency dierences could be due to the dierences in the RT ± PCR methods employed, since a single set of PCR cycles was used in this study and a nested PCR approach was used in one of the previous studies (Virgilio et al., 1996) . Conversely, it could be due to a slightly lower sensitivity of detection of aberrant transcripts present in low abundance when using the single set of 40 PCR cycles. Lastly, it could be due to dierences in cell culture conditions that might lead to dierent levels of expression of the FRA3B fragile site in the cell lines.
Genes are often de®ned and identi®ed as tumor suppressor genes if they conform to the`2 hit' hypothesis (Knudson, 1971) which postulates that loss of both alleles of such genes is required via mutation, deletion, or rearrangement to confer a growth advantage and to contribute to cancer. Critical also to de®ning tumor suppressor genes is identi®cation of biological and/or biochemical activities consistent with tumor or growth suppression. In this study, we sought to determine if the FHIT gene conformed to the ®rst criteria and was altered in human tumors and tumor-derived cell lines. Examination of the FHIT gene at the RNA, DNA, and protein levels revealed a signi®cant frequency of alterations in HNSCC-derived lines which included the presence of aberrant transcripts, aberrant proteins, DNA deletions or rearrangements, and decreased or absent FHIT message and/or protein. We were unable to ®nd any point mutations in exons 4 ± 9 of the gene suggesting that mutation is not a predominant method of inactivation of the FHIT gene. This ®nding is consistent with the results of previous studies which showed very few potentially inactivating point mutations. Our study of primary tumors for alterations at the RNA and protein levels suggested a lower frequency of FHIT alterations in these samples. The reasons for the apparent dierence in frequency of abnormal RT ± PCR products or absence of RT ± PCR products (2/9 vs 4/32 in cell lines vs primary tumors), and aberrant-sized proteins (3/9 vs 1/15 in cell lines vs tumors) is not known but could be related to cell culture conditions, selection and/or immortalization processes as has been described for tumor suppressor genes such as p16. As mentioned above, it might also be related to a decreased ability to detect alterations in tumor samples that contain contaminating normal stromal and in®ltrating cells. Conversely, it is possible that cell culture conditions could lead to a variable and/or higher level of expression of genomic instability around the FRA 3B site in the cell lines vs the primary tumor tissue. This might lead to an increased frequency of aberrant transcripts. Fragile sites are known to be regions of genomic instability and thus increased expression of this site in culture might lead to the higher frequency of aberrant transcripts and proteins detected.
FHIT exhibits dinucleoside 5'5'''-P1,P3 triphosphate hydrolase activity in in vitro assays. Its preferred substrate is Ap3A which it cleaves to ADP and AMP (Barnes et al., 1996) . Alterations and loss of normal FHIT function might thus lead to an increase of Ap3A levels. The consequence of the latter in the context of cell growth or tumor suppression is not known. Although our work showed a low but signi®cant frequency of FHIT alterations at the RNA, DNA, and protein levels, these results and those of others remain to be put in context of mechanistic studies to further de®ne the role of FHIT in tumorigenesis.
Materials and methods
Primary tumors and tumor-derived cell lines
Primary HNSCCs and normal lung tissue for RT ± PCR and SSCP controls were obtained from the tumor bank at Fox Chase Cancer Center. Cell lines derived from squamous cell carcinomas of the oral cavity A253, FADU, and Det 562 as well as the lung tumor-derived line A431 were obtained from ATCC, SCC lines 4, 9, 15, 25, 40 and 66, also derived from the oral cavity, and lines SCC 12 and 13, derived from the skin, were generously provided by Dr James Rheinwald. Primary keratinocyte cultures were obtained from Clonetics, Inc. and were cultured according to Clonetics' recommendations. The 32 primary HNSCCs examined were from the following anatomical locations: tongue: seven samples, metastases to neck with unknown primary: seven samples, larynx: four samples, mandible: three samples,¯oor of mouth: two samples, maxilla: two samples, pyriform sinus: two samples and one sample each from the soft palate, nose, tonsil, pharynx and maxillary sinus.
RNA and DNA isolation
RNA was isolated using Tri Reagent (Sigma, St Louis, MO) according to the manufacturer's directions except that an extra extraction with phenol : chloroform (8 : 1) was performed for the tissue samples. DNA was isolated by standard procedures (Sambrook et al., 1989) . mRNA was isolated from total RNA with micro-oligo (dT) cellulose spin columns (5' Prime 3' Prime, Boulder, CO) according to the manufacturer's instructions.
RT ± PCR
cDNA was synthesized using GIBCO ± BRL Superscript II esentially according to the manufacturer's instruction except that 3 ml of 56 ®rst strand buer were used per 20 ml reaction instead of 4 ml and primer 3D2 was used to prime the ®rst strand synthesis in a 20 ml reaction. Prior to use in the PCR reactions, the cDNA samples were heated to 708C for 15 min and then treated with RNAsin (Promega, Madison, WI).
PCR assays were performed using primers previously described by Ohta et al. (1996) . One ml of RT reaction product was added to each PCR reaction tube containing 19 ml of reaction buer containing 16PCR buer (Perkin Elmer, Foster City, CA), 50 mM primers (3D1, 5U2), 90 mM dNTPs, 7% DMSO and 1.1 U Amplitaq Gold. The reactions were subjected to PCR cycling as follows: one 12 min incubation at 958C to activate Amplitaq Gold (Perkin Elmer), then 40 cycles of 948C 1 min, 578C 1 min, 728C 1 min 10 s followed by a 10 min soak at 728C.
Cloning and sequencing of RT ± PCR products RT ± PCR products were cloned into the Zero Blunt PCR Cloning vector (Invitrogen, Carlsbad, CA) essentially according to the manufacturer's instructions. The clones were sequenced using¯uorescein dyes on an automated ABI Sequencer 377XL (Perkin Elmer, Foster City, CA).
Northern analysis
Approximately 2 mg of mRNA were loaded in each lane of a 1% agarose gel containing 0.66 M formaldehyde and 16MOPS. The gel was transferred to a Hybond N (Amersham, Arlington Heights, IL) membrane by capillary transfer in 106SSC overnight. The membrane was prehybridized at 428C in 50% formamide, 66SSC, 56Denhardts, 0.5% SDS and 0.1 mg/ml salmon sperm DNA then was hybridized with PCR-generated randomprimed full length FHIT or actin probes in 50% formamide, 56SSC, 16Denhardts, 0.5% SDS, 10% dextran sulfate, and 0.1 mg/ml salmon sperm DNA. The ®lter was washed in 26SSC, 0.1% SDS then in 0.16SSC, 0.1% SDS at 658C. Autoradiography was performed for 1 ± 2 h (actin) to 4 days (FHIT).
Single stranded conformation polymorphism (SSCP) analysis
Exons 4 ± 9 were ampli®ed using intron-based primer sequences generously provided prior to publication by Dr Kay Huebner that are described by Druck et al. (1997) . 50 ng of genomic DNA was used in each PCR reaction that contained 16PCR buer, 50 mM dNTPs, 1.2 mM primers, 1 U Taq polymerase, 1 mCi [ 32 P]dCTP. The samples were diluted 1 : 12 in 0.1% SDS, 10 mM EDTA then 1 : 1 in sequencing stop solution. Each sample was run under two dierent sets of SSCP gel and running conditions. One gel consisting of 16TBE, 10% glycerol, and 6% acrylamide was run in 16TBE. The second gel contained 0.56TBE, 5% glycerol, and 6% acrylamide and was run in 0.56TBE. Both gels were run overnight at 5 ± 7 W at room temperature. Following electrophoresis, the gels were dried then subjected to autoradiography. Aberrant bands were cut out, puri®ed away from the acrylamide, then reampli®ed by PCR for automated sequencing.
Recombinant Fhit protein and polyclonal antibodies
Full-length coding region of human FHIT cDNA was PCR-ampli®ed from a human brain library based on published sequence and cloned into bacterial expression vector, pGEX-4T (Pharmacia, Piscataway, NJ). JM109 bacteria transformed with pGEX-FHIT were grown to an O.D. of 0.8 at 600 nm and induced with 0.1 mM IPTG for 2 h at 378C. The cells were pelleted, resuspended in 1/20 volume of PBS and lysed by sonication. Lysate was mixed gently for 30 min at 48C in the presence of 1% Triton X-100 and centrifuged at 12 000 g for 10 min at 48C. The GST-fusion protein was puri®ed from the supernatant with glutathione Sepharose 4B anity matrix (Pharmacia, Piscataway, NJ). It was used, along with Freund's adjuvant, to immunize New Zealand white rabbits to generate crude anti-sera. Speci®city of the antibodies was tested against the recombinant protein, and in blocking experiments with the test and control antigens (Figure 2 and Xiao et al., 1997) .
Immunoblotting analysis
Cells and tissues were homogenized in lysis buer (10 mM Tris HCl, pH 7.4, 150 mM NaCl, 1% NP-40, 1 mM EDTA, 1 mM DTT, 0.5 mM PMSF, 10 mg/ml aprotinin, 5 mg/ml leupeptin) and clari®ed by centrifugation and the concentrations were quantitated by Bradford assay. One hundred micrograms of protein per sample were fractionated in 15% SDS ± PAGE gel and blotted onto nitrocellulose membrane. After blocking with 5% non-fat dried milk/ 0.1% Tween 20 in PBS, the blots were incubated with crude anti-serum (1 : 2000). Signals were detected using the ECL system following the manufacturer's protocol (Amersham, Arlington Heights, IL).
Southern analyses
10 mg of genomic DNA was cut with HindIII overnight at 378C. The restricted DNA was electrophoresed on a 0.8% agarose/Synergel overnight then transferred by capillary action to a Hybond N + membrane in 0.4 M NaOH. The membrane was prehybridized in 10% SDS, 7% PEG, 200 mg/ml salmon sperm DNA and then hybridized in the same buer containing a random-primed FHIT probe generated by PCR to contain the full FHIT cDNA except for sequences 3' to exon 10. The ®lters were washed under stringent conditions (0.16SSPE, 0.1% SDS at 658C) and then exposed to autoradiography.
